An Official publication of The Asian Congress of Neurological Surgeons (AsianCNS)

Search Article
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Advertise Subscribe Contacts Login  Facebook Tweeter
  Users Online: 395 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

   Table of Contents      
REVIEW ARTICLE
Year : 2018  |  Volume : 13  |  Issue : 1  |  Page : 1-8

Review of surgical anatomy of the tumors involving cavernous sinus


Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China

Date of Web Publication6-Feb-2018

Correspondence Address:
Songtao Qi
Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou - 510 515, Guangdong
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ajns.AJNS_26_16

Rights and Permissions
  Abstract 


The lesions involving cavernous sinus (CS) and lateral sellar region includes tumors, vascular lesions, infection, inflammation, and trauma. Tumors associated with CS cause significant distortion of the microanatomy posing an additional surgical challenge to the neurosurgeons. The surgical approach and microsurgical anatomy with respect to the origin and growth of the tumor within the CS region have not been comprehensively described in recent years. We conducted a review of literature concerning CS and associated tumors, complied through MEDLINE/OVID and using cross-references of articles on PubMed with the keywords cavernous sinus, CS tumors, pituitary adenoma, meningioma, schwannoma, chordoma, CS hemangiomas, extradural, interdural, intradural, skull base, gamma knife radiosurgery, endoscopic endonasal approach. Based on the tumor origin and growth pattern, the tumors associated with CS can be classified into three categories: Type-I: tumor originating from CS, Type-II: originating from lateral wall of CS, and Type-III: extraneous origin and occupying CS. The review focuses on approach to a tumor within each type of tumor in the CS region. The emphasis is that the tumor growth pattern and significant distortion of the CS anatomy caused by the tumor growth should be considered while planning the optimal surgical approach for tumors in this region to ensure complete tumor resection with minimal neurovascular morbidity.

Keywords: Anatomy, cavernous sinus, meningioma, tumors


How to cite this article:
Chotai S, Liu Y, Qi S. Review of surgical anatomy of the tumors involving cavernous sinus. Asian J Neurosurg 2018;13:1-8

How to cite this URL:
Chotai S, Liu Y, Qi S. Review of surgical anatomy of the tumors involving cavernous sinus. Asian J Neurosurg [serial online] 2018 [cited 2018 Feb 18];13:1-8. Available from: http://www.asianjns.org/text.asp?2018/13/1/1/224836




  Introduction Top


Since the seminal description of cavernous sinus (CS) as the “anatomical jewel box” and surgical “no man's land,” numerous studies have contributed to the understanding of microsurgical anatomy of CS.[1] The normal microsurgical anatomy of CS and the triangular corridors to approach the CS are well described in literature.[1],[2],[3],[4],[5],[6] The understanding of the borders and walls that contains the CS is vital to determine the accurate orientation of tumor in relation to the surrounding neurovascular structures. The anterior CS border consists of anterior clinoid and superior orbital fissure, posteriorly the petrous tip and posterior clinoid, medial extent is to the sella and sphenoid body, and lateral extent is the junction of the greater wing of sphenoid. The wall containing CS includes anterior, lateral, medial, posterior, and inferior walls.[6] The medial wall of CS can be divided into sellar and sphenoidal part. The description of the medial CS wall in literature varies.[7],[8] Some authors describe medial wall as a single meager membrane, others described the medial wall as a distinct dural layer, composed of the loosely arranged collagen fibers with mean thickness of 0.195 ± 0.066 mm[9] while in our previous study, we found it to be a bilayered membrane with lateral part of the pituitary capsule and the fibrous layer forming the two layers, thus making medial wall a double-membrane structure rather than double dural structure.[10] The lateral CS wall is described as a two-dural layer with the cranial nerves (CNs) III, IV, and VI traversing between these layers.[6],[11],[12],[13] Janjua et al.[14] have described an intermediate layer (fibrous contribution to the meningeal dura) that decreases in thickness posteriorly and laterally. The authors recommended that choosing the dissection plane between meningeal dura and intermediate layer for an extradural exposure might yield additional protection to the CNs in membranous layer. These anatomical layers are basis of planning the surgical approach to the lesions in and around CS.

The pioneer description of surgical entry point into CS by Parkinson and West and Dolenc has been adopted by most neurosurgeons operating in this region.[3],[11] The approach selection is mainly based on exact location of lesion in and around the CS. The lesions affecting CS include vascular, neoplastic, infective, and inflammatory lesions arising in the CS proper or through extension from adjacent intra- and extra-cranial regions. The lesions such as intracavernous aneurysm and arteriovenous fistulae are generally smaller and do not cause significant distortion; hence, direct approach to these lesions based on the triangular corridors and anatomical dural layers is feasible.[15] However, the tumors involving CS, when reach a certain size, might develop a large degree of anatomical distortion making the identification of anatomy and optimal surgical planes difficult. Therefore, understanding the surgical anatomy with respect to the tumor origin and growth pattern is important. The tumors in the CS region can be classified based on the origin, growth pattern, and concept of membrane structures forming CS wall. In the present review, we discuss the tumors based on their origin and invasion into CS and discuss pertinent surgical approaches as well as current concepts on management strategy for tumors originating and/or invading the CS.


  Methods Top


We conducted a review of literature concerning CS and associated tumors, complied through MEDLINE/OVID and using cross-references of articles on PubMed with the keywords cavernous sinus, cavernous sinus tumors, pituitary adenoma, meningioma, schwannoma, chordoma, CS hemangiomas, extradural, interdural, intradural, skull base, gamma knife radiosurgery, and endoscopic endonasal approach.


  Results Top


Based on the tumor origin and growth pattern, the tumors associated with CS can be classified into three categories: Type-I: tumor originating from CS, Type-II: originating from lateral wall of CS, and Type-III: extraneous origin and occupying CS. The review focuses on approach to a tumor within each type of tumor in the CS region.


  Discussion Top


CS tumors can be divided into three types [Figure 1]:[16],[17] Type-I: tumor originating from CS [Figure 2]a,[Figure 2]b,[Figure 2]c, Type-II: originating from lateral wall of CS [Figure 2]d, and Type-III: extraneous origin and occupying CS [Figure 2]e and [Figure 2]f.
Figure 1: Cavernous sinus tumors can be divided into three types: (a) Type-I: The tumor originating from the cavernous sinus area, (b) Type-II: From the lateral wall of cavernous sinus, (c and d) Type-III: Extraneous origin and compressing the cavernous sinus, and (d) invading the cavernous sinus wall

Click here to view
Figure 2: (a-c) T1-weighted magnetic resonance imaging demonstrating the cavernous hemangioma in cavernous sinus (Type-I), (d) T1-weighted magnetic resonance imaging demonstrating the trigeminal neurinoma extending to and between the lateral wall of cavernous sinus (Type-II), (e) sphenoid wing meningioma extending to the lateral cavernous sinus wall (Type-III), (f) nasopharyngeal carcinoma invading the cavernous sinus (Type-III)

Click here to view


Type-I: Tumor originating from the cavernous sinus

  1. CS cavernous hemangiomas are benign and the only primary intracavernous tumor; accounting for 13% of all intracranial cavernous hemangioma, 3% of benign tumors of the CS area, 2% of all tumors within the CS area, and 0.4%–2% of intracranial vascular malformations.[18],[19] Complete or partial resection of cavernous hemangioma is the preferred treatment option; due to vascular nature of these lesions and complex neurovascular relations, complete excision is a challenge

    A variety of surgical approaches to the CS hemangiomas have been described; type of craniotomy varies depending on location of tumor and local invasion to the sella versus middle fossa. The modified pterional transzygomatic craniotomy and extirpation of the hemangioma by extradural approach are by far the most adopted approach. We attempt complete excision of cavernous hemangioma in all cases without dissecting the pseudocapsule. The interface between the pseudocapsule and duramater can be utilized as a barrier to protect CNs [Figure 2]a. Despite successful resections carried out, the mortality rates still remain high, owing to the eminent possibility of profuse bleeding during surgical intervention combined with potential for long-term CN deficits.

    Stereotactic radiosurgery has demonstrated good postoperative results as primary and adjunct therapy.[20],[21] The radiation-induced thrombosis of tumor blood vessels reduces tumor volume which leads to reduction in size or arrest in tumor growth with resolution of the symptoms of CN compression.[21],[22],[23],[24] The scar formation with preoperative radiation might impede subsequent surgical resection. Treatment of small lesions with radiosurgery and large ones with fractionated stereotactic radiotherapy is still controversial. We adopt the strategy of employing stereotactic radiosurgery for small tumors (<3 cm) with CN involvement as the only presenting symptom. For tumors >3 cm in size, preoperative conventional radiation therapy is used to shrink the tumor and repress intraoperative bleeding.
  2. Another group of tumors that can be classified in this group are metastasis to CS; which are associated with poor prognosis and treatment is largely palliative. Radiosurgery is often used to deal with the CN compression symptoms.


Type-II: Originating from the lateral wall of cavernous sinus

Meningiomas and schwannomas constitute the most common primary tumors originating from lateral CS wall.

  1. Meningioma: Kehrli et al.[25] demonstrated that arachnoid granulations of CNs in lateral CS wall are the possible origin of meningioma in this region. The meningiomas originating from lateral CS wall tend to confine between outer and inner layer of the lateral wall [Figure 3]b. In this case, complete tumor resection can be achieved by working in between two dural layers. However, extension or invasion into CS or surrounding structures is not uncommon.[26],[27] Meningiomas arising from around the Meckel's cave have a tendency to invade the lateral CS wall leaving no clear dissection plane between the tumor and CNs, especially between the abducens nerve and tumor.[28] Internal carotid artery (ICA) invasion might occur without any preoperative imaging evidence of arterial narrowing. Complete resection of such invasive meningioma can be challenging due to significant morbidity associated with the risk of ICA and CN damage. Many neurosurgeons aim at achieving subtotal resection as an effective means to achieve tumor control and symptomatic relief of compressive cranial neuropathies.[29],[30] For large meningioma that is not invasive, simple extradural dissection might not suffice; this is discussed at length in the extradural approach section in this paper. Gross-total resection of CS-associated meningioma has been reported in 20%–76% of published cases.[31],[32] CN involvement has been a critical issue while attempting complete resection of CS meningiomas.[27] DeMonte et al. reported postoperative improvement in 14% of preoperatively affected CNs, no change in 80% of patients, and 10 new neuropathies after the CS meningioma resection;[33] no other report on significant improvement in postoperative CN morbidity was available for review. Sughrue et al. in their meta-analysis [34] reported that primary or supplement radiation offers a successful alternative to microsurgery for meningioma involving CS
  2. Trigeminal schwannomas: Trigeminal schwannoma (TS) that originates from the trigeminal ganglion in the outer layer of lateral wall and perches in the CS could be classified precisely based on the origin as Type-II [Figure 2]d. TS are positioned posteriorly within the lateral CS wall and may show extension into the posterior fossa. Historically, epidural and interdural middle fossa approaches are employed to achieve complete resection of these tumors.[35] Schwannomas are distinctly separated from the CS by inner layer. Although large tumors tend to extend into CS, they usually do not invade venous plexus, CN, and carotid artery.[28] Thereby, achieving complete resection of tumor while preserving major trigeminal nerve fibers and other CNs is feasible in most cases. CS involvement is treated by both surgery and radiosurgery to minimize the postoperative complications. The controversy exists on decompression followed by radiation versus primary gamma knife radiosurgery for these tumors.[36] For the patients undergoing primary radiosurgery, additional surgical treatment after gamma knife surgery due to tumor enlargement or uncontrolled facial pain is warranted in many cases.[36],[37]
Figure 3: (a) Intraoperative view showing the lateral CS wall exposure; CN II, ICA, CN III, and lateral wall of CS, (b) meningioma (Type-II) between the outer and inner layer of the lateral CS wall; ICA – Internal carotid artery; CS – Cavernous sinus; CN III – Cranial nerve III; CN II – Cranial nerve II; T – Tumor

Click here to view


Type-III: Extraneous origin and compressing/invading the cavernous sinus

  1. Pituitary adenoma: CS invasion rate for parasellar pituitary adenoma is reported in the range of 15%–20%.[38],[39] As yet, the route of pituitary adenoma invasion in parasellar region is controversial. Some researchers advocate that pituitary adenomas being biologically benign, the parasellar infiltration is due to histological defect in medial CS wall [8],[38] while others have postulated that the biological behavior of tumor aids infiltration.[7],[40] Regardless of the route of invasion preoperative diagnosis of CS invasion has been the subject of debate in recent studies. The contemporary neuroimaging has failed to delineate the medial CS wall, which otherwise would aid in prediction of CS invasion. The distance between the two sides of the ICA is commonly used criteria to gauge the adenoma invasion. Frank and Pasquini [39] provided the five grade endoscopic classification system for the CS invasion, where Grade 2 and over are considered as CS invasion. Ceylan et al.[38] reported that the invasion of pituitary adenoma into CS is more common from medial corridors compared to lateral surgical corridors (endoscopic surgery corridors). Although, not generally accepted, another concept is that the pituitary adenoma does not actually invade CS, the tumor growth pushes covering membranes and medial wall toward the CS. The two layers of pituitary become thinner as tumor grows but separates the tumor and the CS.[10] Based on this concept, the parasellar extension of pituitary adenoma can be resected without opening the medial CS wall. The residual or recurrent tumors are treated by radiosurgery and are characterized by high rates of local control and endocrine remission
  2. Chordoma and chordosarcomas: Another tumor extending to CS is the chordoma. Gross radical removal of chordomas and chondrosarcomas involving the CS has been accomplished with an acceptable surgical morbidity.[41] In chordomas and chondrosarcomas, compression of CS is more frequently seen than its invasion [Figure 4]b and [Figure 4]c; however, delineation between compression and invasion is arduous. The tumor growing from skull base pushes CS wall and compresses it between the tumor and CS. This leads to thin and weakened wall, which is often missed to view and respect during surgery, which might result in direct inadvertent entry into CS. Hence, even though this tumor does not invade the CS, it might be safer to consider this as Type-I tumor. Multimodality treatment with surgical resection employing skull base approaches, endoscopic endonasal transcavernous approach, and radiosurgery have increased the propensity of complete resection with decreased CN morbidities, especially for lateralized chordomas or when tumors intimately involve the ICA or CS.[41],[42],[43] However, in case of recurrence, the previous radiotherapy increases the risk of mortality in both the postoperative and follow-up period [44]
  3. Nasopharyngeal carcinoma: Nasopharyngeal carcinoma has tendency to invade the CS through inferior and lateral CS walls. These lesions invade CS by direct skull-base invasion, perineural spread along the V2 or V3, or extension through the foramen lacerum. The aim of the surgical treatment is to relieve the compressive CN symptoms, which is often achieved by partial tumor resection [Figure 2]f. Stereotactic radiosurgery performed early is deemed to be a good alternate palliative measure for improving the CN deficits [45],[46]
  4. Petroclival meningioma (PCM): PCMs are located in the anatomical complex region involving the dural folds, venous sinuses, and CNs. The surgical resection gets further challenging with extension of PCM to CS through posterior wall.[47] PCM often tends to compress the posterior and lateral CS wall rather than invading the CS [Figure 4]a. For the residual or recurrent PCM, stereotactic radiosurgery is favorable treatment option.[48] However, with evolving anatomical and clinical studies of tumors in this region, better outcomes with surgical resection can be anticipated. Subtemporal approach with anterior petrosectomy and extended retrosigmoid approach allow exposure of the posterior CS by dividing the dura medial to the entry point of trochlear nerve into the tentorium, which allows for the exposure of the intracavernous ICA.[49] The accessibility to the posterior CS region through retrosigmoid approach might be further optimized by the endoscopic-assisted techniques; where entry to the middle fossa and the CS can be achieved through intradural suprameatal approach. The endoscope can be inserted parallel to the posterior surface of the petrous bone toward the Meckel's cave and the channelized to follow the cisternal anatomy to the posterior CS [50]
  5. Finally, meningioma originating through the sphenoid ridge and invading the CS can be classified into Type-III. The characteristics of these invading meningiomas, surgical concepts, and challenges could be compared to the large aggressive meningioma originating in the lateral wall and invading the CS (Type-II).
Figure 4: (a) Intraoperative view of the meningioma from the right petrous apex, compressing cavernous sinus, without invading the wall of cavernous sinus (Type-III); (b) Intraoperative view of chordoma invading the cavernous sinus through posterior cavernous sinus wall (Type-III); (c) intraoperative view showing the tumor after opening outer cavernous sinus wall; VII-Cranial nerve VII. PA – Petrous apex; T – Tumor; CN III – Cranial nerve III; PCR – Posterior clinoid region; CS – Cavernous sinus; ICA – Internal carotid artery; LN-II – Left cranial nerve II; RN-II – Right cranial nerve II

Click here to view


Surgical approach selection based on the classification

The triangular spaces around the CS are natural corridors through which the intracavernous lesions might be accessed. However, tumors in the CS area make the identification of triangular anatomy very difficult. Nonetheless, the orientation of the access gained by each of these corridors is paramount to achieve direct control and visualization of the ICA and CNs. The access to roof of CS and subclinoidal segment of ICA can be achieved by drilling the anterior clinoid through clinoidal triangle. For tumors involving medial CS and for approaches to the interpedunular fossa, the oculomotor triangle is an important access corridor. The entry through surpratrochlear triangle is utilized to expose the posterior band of the intracavernous carotid artery and meningohypophyseal and inferolateral trunk. Another entry zone for the meningohyophyseal trunk is the infratrochlear or Parkinson's triangle; sixth nerve can be exposed through this triangle. This corridor provides a lateral and direct entry to the CS and has been utilized by many neurosurgeons as a safe entry zone for the lateral intradural approach to CS lesions. The four middle fossa triangles including anteromedial, anterolateral, posterolateral, and posteromedial triangles have been utilized as the natural corridor for various tumors. For instance, opening the anteromedial triangle between the V1 and V2 and displacing V1 exposes the sixth nerve, which is important to identify and preserve when dissecting the tumor invading the CS, particularly for Type-II meningiomas and Type-I cavernous hemangiomas. This anteromedial corridor is employed for the superior extradural approach. For the Type-I tumors with anterolateral extension and Type-II tumor with intracavernous extension, anterolateral middle fossa triangle can be opened. Posteromedial or Kawase's and posterolateral or Glasscock's triangles are corridors for the combined lateral and inferolateral approach to CS. The entry to posterior CS can be gained by posteromedial or Kawase's triangle. In addition, the posteromedial triangle forms boundaries for drilling the petrous apex and for entry to the posterior fossa. The approaches to the CS can be broadly classified as either extradural or intradural and combined extradural intradural approach.

A number of surgical approaches are utilized for the entry into the CS through superior, lateral, posterior, medial, and inferior walls.[18],[32],[35],[49],[50],[51],[52],[53] Orbitozygomatic approach (OZ) provides wide exposure to the entire CS with minimal cerebral retraction; for the additional posterior exposure, extended middle fossa transzygomatic approach can be used. The commonly used approaches including pterional approach (entry through superior wall), anterior subtemporal approach (through lateral wall), transpetrosal-transtentorial approach (posterior wall), contralateral pterional transsylvian approach (medial wall), and transsphenoidal approach through inferior wall are commonly used.

Extradural approach

Extradural or epidural approach to the CS for trigeminal neuroinoma was pioneered by Dolenc et al., which involved peeling off the outer layer from the inner layer which allows exposure of CNs coursing in semitransparent inner layer of the lateral CS wall. As the surgical procedure is performed substantially in the interdural space, this approach is also referred as interdural approach.[54] This approach offers advantages of complete exposure of tumor bed, swift control of intraoperative bleeding, extracavernous resection, tumor removal with CN in surgeon vicinity, minimal brain injury due to no direct brain retraction and thereby reducing the incidence of iatrogenic subarachnoid hemorrhage, and reduced possibility of intracranial infections. This extradural/interdural approach utilizes the inner wall, which not only acts as the mechanical barrier but also protects the vasa-nervosum that originates from intracavernous carotid and ascends through the inner wall. For Type-II tumors [Figure 3]a and [Figure 3]b, working in between the outer and inner lateral wall of CS enables resection of tumor without compromising the blood supply to the CNs. The CN between the layers of the lateral wall of CS is usually severely adhered to tumor and is pushed in different directions as the tumor grows. The preoperative knowledge of tumor origin and position of CNs might aid in designing the surgical approaches. For instance, if the nerves were pushed medially or superiorly, lateral wall approach can be used, while if the CNs are lateral or inferior, the approach through roof of CS can be employed. This strategy would expose the tumor first, which would allow direct control on tumor while identifying and exposing the CNs. The separation of outer layer and selecting incision site on outer layer must be based on tumor size and growth direction; for a medium to large tumor, the area that is bulged out can be safely incised with a laser knife in the direction of tumor growth.

The large tumor of Type-II, III might damage the thin inner layer; so after opening the outer layer and while working in the interdural space, the inner membrane can give way leading to direct entry into CS; then, control of bleeding is a challenge [Supplemental Video 1]. Based on this, the larger tumors of Type-II and Type-III even if do not invade the CS necessitate working within the CS and can be classified as Type-I. Conventionally, the use of thin layer of gelatin sponge and bipolar coagulation around the opening gradually controls the bleeding. Safe and effective hemostasis can be achieved with the use of microfibrillar collagen hemostat or fleece-coated fibrin glue patch applied over the opened CS with gentle compression. Fibrin glue injection between V1 and V2 obliterates the lateral CS compartment, and injection posterior to the clinoidal segment of ICA obliterates the medial compartment and thereby facilitates visualization during surgery and decreases blood loss.[55]




In addition, the large tumors might push CNs laterally which are then first encountered, increasing the risk of CN damage. Another challenge with larger tumor might be excessive temporal lobe retraction for optimal tumor exposure, which increases the risk of injury due to increase splitting of brain tissue. Consequently, for large tumors, when the temporal lobe is required to be being elevated more than 3 cm, intradural approach could be more suitable. The ideal tumor that could be safely resected by extradural/interdural approach would be a small- to medium-sized Type-II and Type-III tumors, which either remains confined within the two layer of lateral, medial, posterior, and inferior CS wall or compress the outer layer of CS wall without significant distortion.

Intradural approach

The triangular spaces around the CS are natural corridors through which the intracavernous lesions can be accessed. The normal anatomy of CS and middle fossa triangles has been well described in literature.[1],[2],[3],[4],[5],[6] The direct access to CS through the roof can be achieved by intradural transsylvian route with drilling of the anterior clinoid process and superior wall of the optic canal and opening the optic nerve sheath. The roof is exposed at exit point of ICA from CS. This approach is traditionally used for the lesions adjacent to anterior loop of the ICA as well as those superior and/or medial to the cavernous ICA. The intradural approach from lateral wall into CS is through the Parkinson triangle or at the point of maxillary branch of trigeminal nerve on the lateral wall.[11] The lateral approach provides optimal exposure to the lesions that are lateral and/or inferior to ICA and those posteriorly located within the CS (Type-II and III tumors). The superior and lateral approaches can be combined for lesions widely involving the CS. For Type-I tumors or larger Type-II, where the lateral wall might be enlarged and distorted and/or the CS cavity might be occupied or compressed by tumor; the intradural approach could be considered. Intradural approach allows wider field of vision and direct exposure to the tumor in CS area. However, it precludes the exact determination of CN entry points rendering partly unsighted resection. Further, the opening of dura could channelize the blood to subarachnoid space, increasing the risk of postoperative complications.

Transsphenoidal endonasal endoscopic approach

Endoscopic endonasal approach is alternative to the medial approach to CS; offering improved visualization and low morbidity compared to microscopic transsphenoidal route.[39],[56] Three different surgical approaches have been employed to access the CS: the paraseptal, middle meatal, and middle turbinectomy approaches.[57] Although medial to lateral endonasal approach can be utilized for variety of tumors involving CS (Type-I and III), based on the consistency, site of origin of the tumor, and the risk to the patient, lateral to medial approaches (for Type-I) may be required to control tumor growth in the lateral CS wall. Type-II lesions might not be suitable for this approach due to downward displacement of ICA and CNs. The ideal lesions for endoscopic endonasal approach are small to medium volume soft tumors with minimal chances of ICA infiltration and with a mediolateral growth leading to lateral displacement of CNs.[56],[57] The potential setbacks of this approach include complications such as CN injury, ICA rupture, cerebrospinal fluid leak, and associated steep learning curve. However, with increasing use of neuronavigation, imaging, and newer angled endoscopes with better two-dimensional and three-dimensional image acquisition, more neurosurgeons are incorporating endoscopic surgery. Another such avenue recently described in the keyhole endoscopic subtemporal approach to lateral CS; the use of which is in infantile stage for the lesions in and around CS and is limited to the cadaveric studies.[58]


  Conclusion Top


Classification of tumors in CS area based on their origin and growth pattern would facilitate optimal approach selection to anticipate better surgical outcomes. The membranes around the CS form a natural barrier to intracavernous neurovascular structures. Type-I tumors necessitate opening of CS; small- to medium-sized Type-II and III can be dealt with by working between the outer and inner layers of medial, lateral, superior, or inferior wall of the CS. However, large and aggressive Type-II or Type-III tumors could compress and damage the thin inner layer, which might be distorted at the beginning or give way while working in between the two layers. Therefore, the large Type-II and Type-III tumors can be treated as Type-I tumor.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Parkinson D. Lateral sellar compartment O.T. (cavernous sinus): History, anatomy, terminology. Anat Rec 1998;251:486-90.  Back to cited text no. 1
    
2.
Campero A, Campero AA, Martins C, Yasuda A, Rhoton AL Jr. Surgical anatomy of the dural walls of the cavernous sinus. J Clin Neurosci 2010;17:746-50.  Back to cited text no. 2
[PUBMED]    
3.
Dolenc V. Anatomy and Surgery of the Cavernous Sinus. Berlin: Springer; 1989.  Back to cited text no. 3
    
4.
Isolan GR, Krayenbühl N, de Oliveira E, Al-Mefty O. Microsurgical anatomy of the cavernous sinus: Measurements of the triangles in and around it. Skull Base 2007;17:357-67.  Back to cited text no. 4
    
5.
Kawase T, van Loveren H, Keller JT, Tew JM. Meningeal architecture of the cavernous sinus: Clinical and surgical implications. Neurosurgery 1996;39:527-34.  Back to cited text no. 5
[PUBMED]    
6.
Rhoton AL Jr. The cavernous sinus, the cavernous venous plexus, and the carotid collar. Neurosurgery 2002;51 4 Suppl:S375-410.  Back to cited text no. 6
    
7.
Yasuda A, Campero A, Martins C, Rhoton AL Jr., Ribas GC. The medial wall of the cavernous sinus: Microsurgical anatomy. Neurosurgery 2004;55:179-89.  Back to cited text no. 7
    
8.
Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu JI. Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 2001;49:857-62.  Back to cited text no. 8
[PUBMED]    
9.
Yilmazlar S, Kocaeli H, Aydiner F, Korfali E. Medial portion of the cavernous sinus: Quantitative analysis of the medial wall. Clin Anat 2005;18:416-22.  Back to cited text no. 9
[PUBMED]    
10.
Songtao Q, Yuntao L, Jun P, Chuanping H, Xiaofeng S. Membranous layers of the pituitary gland: Histological anatomic study and related clinical issues. Neurosurgery 2009;64 3 Suppl:ons1-9.  Back to cited text no. 10
    
11.
Parkinson D, West M. Lesions of the cavernous plexus region. In: Youmans JR, editor. Neurological Surgery. Philadelphia: WB Saunders; 1990. p. 3351-70.  Back to cited text no. 11
    
12.
Umansky F, Nathan H. The lateral wall of the cavernous sinus. With special reference to the nerves related to it. J Neurosurg 1982;56:228-34.  Back to cited text no. 12
[PUBMED]    
13.
Peker S, Kurtkaya-Yapicier O, Kiliç T, Pamir MN. Microsurgical anatomy of the lateral walls of the pituitary fossa. Acta Neurochir (Wien) 2005;147:641-8.  Back to cited text no. 13
    
14.
Janjua RM, Al-Mefty O, Densler DW, Shields CB. Dural relationships of Meckel cave and lateral wall of the cavernous sinus. Neurosurg Focus 2008;25:E2.  Back to cited text no. 14
    
15.
Yasuda A, Campero A, Martins C, Rhoton AL Jr., de Oliveira E, Ribas GC. Microsurgical anatomy and approaches to the cavernous sinus. Neurosurgery 2008;62 6 Suppl 3:1240-63.  Back to cited text no. 15
    
16.
el-Kalliny M, van Loveren H, Keller JT, Tew JM Jr. Tumors of the lateral wall of the cavernous sinus. J Neurosurg 1992;77:508-14.  Back to cited text no. 16
[PUBMED]    
17.
Tu YK, Tseng MY, Liu HM. Experience in surgical management of tumours involving the cavernous sinus. J Clin Neurosci 2000;7:419-24.  Back to cited text no. 17
[PUBMED]    
18.
Goel A. The extradural approach to lesions involving the cavernous sinus. Br J Neurosurg 1997;11:134-8.  Back to cited text no. 18
[PUBMED]    
19.
Zabramski M, Awasthi D. Extra-axial cavernous malformations. In: Award IA, Barrow DI, editors. Cavernous Malformations. Park Ridge: American Association of Neurological Surgeons; 1993. p. 133-44.  Back to cited text no. 19
    
20.
Thompson TP, Lunsford LD, Flickinger JC. Radiosurgery for hemangiomas of the cavernous sinus and orbit: Technical case report. Neurosurgery 2000;47:778-83.  Back to cited text no. 20
[PUBMED]    
21.
Wang X, Mei G, Liu X, Dai J, Pan L, Wang E. The role of stereotactic radiosurgery in cavernous sinus hemangiomas: A systematic review and meta-analysis. J Neurooncol 2012;107:239-45.  Back to cited text no. 21
[PUBMED]    
22.
Nakamura N, Shin M, Tago M, Terahara A, Kurita H, Nakagawa K, et al. Gamma knife radiosurgery for cavernous hemangiomas in the cavernous sinus. Report of three cases. J Neurosurg 2002;97 5 Suppl:477-80.  Back to cited text no. 22
    
23.
Peker S, Kiliç T, Sengöz M, Pamir MN. Radiosurgical treatment of cavernous sinus cavernous haemangiomas. Acta Neurochir (Wien) 2004;146:337-41.  Back to cited text no. 23
    
24.
Iwai Y, Yamanaka K, Nakajima H, Yasui T. Stereotactic radiosurgery for cavernous sinus cavernous hemangioma – case report. Neurol Med Chir (Tokyo) 1999;39:288-90.  Back to cited text no. 24
[PUBMED]    
25.
Kehrli P, Maillot C, Wolff Quenot MJ. Sheaths of cranial nerves in the lateral wall of the cavernous sinus. An embryological and anatomical study. Neurochirurgie 1995;41:403-12.  Back to cited text no. 25
[PUBMED]    
26.
Goel A, Kothari M. Cavernous sinus meningiomas. J Neurosurg 2010;113:1085.  Back to cited text no. 26
[PUBMED]    
27.
Sen C, Hague K. Meningiomas involving the cavernous sinus: Histological factors affecting the degree of resection. J Neurosurg 1997;87:535-43.  Back to cited text no. 27
[PUBMED]    
28.
Muto J, Kawase T, Yoshida K. Meckel's cave tumors: Relation to the meninges and minimally invasive approaches for surgery: Anatomic and clinical studies. Neurosurgery 2010;67:ons291-8.  Back to cited text no. 28
[PUBMED]    
29.
O'Sullivan MG, van Loveren HR, Tew JM Jr. The surgical resectability of meningiomas of the cavernous sinus. Neurosurgery 1997;40:238-44.  Back to cited text no. 29
    
30.
Couldwell WT, Kan P, Liu JK, Apfelbaum RI. Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical note. J Neurosurg 2006;105:148-52.  Back to cited text no. 30
[PUBMED]    
31.
De Jesús O, Sekhar LN, Parikh HK, Wright DC, Wagner DP. Long-term follow-up of patients with meningiomas involving the cavernous sinus: Recurrence, progression, and quality of life. Neurosurgery 1996;39:915-9.  Back to cited text no. 31
    
32.
Heth JA, Al-Mefty O. Cavernous sinus meningiomas. Neurosurg Focus 2003;14:1-9.  Back to cited text no. 32
    
33.
DeMonte F, Smith HK, al-Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 1994;81:245-51.  Back to cited text no. 33
[PUBMED]    
34.
Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 2010;113:1087-92.  Back to cited text no. 34
[PUBMED]    
35.
Dolenc VV. Frontotemporal epidural approach to trigeminal neurinomas. Acta Neurochir (Wien) 1994;130:55-65.  Back to cited text no. 35
[PUBMED]    
36.
Fukaya R, Yoshida K, Ohira T, Kawase T. Trigeminal schwannomas: Experience with 57 cases and a review of the literature. Neurosurg Rev 2010;34:159-71.  Back to cited text no. 36
[PUBMED]    
37.
Hasegawa T, Kida Y, Yoshimoto M, Koike J. Trigeminal schwannomas: Results of gamma knife surgery in 37 cases. J Neurosurg 2007;106:18-23.  Back to cited text no. 37
[PUBMED]    
38.
Ceylan S, Anik I, Koc K. A new endoscopic surgical classification and invasion criteria for pituitary adenomas involving the cavernous sinus. Turk Neurosurg 2011;21:330-9.  Back to cited text no. 38
[PUBMED]    
39.
Frank G, Pasquini E. Endoscopic Endonasal Cavernous Sinus Surgery, with Special Reference to Pituitary Adenomas. Pituitary Surgery - A Modern Approach Front Horm Res 2006;34:64-82.  Back to cited text no. 39
    
40.
Ceylan S, Anik I, Koc K, Kokturk S, Ceylan S, Cine N, et al. Microsurgical anatomy of membranous layers of the pituitary gland and the expression of extracellular matrix collagenous proteins. Acta Neurochir (Wien) 2011;153:2435-43.  Back to cited text no. 40
[PUBMED]    
41.
Lanzino G, Sekhar LN, Hirsch WL, Sen CN, Pomonis S, Snyderman CH. Chordomas and chondrosarcomas involving the cavernous sinus: Review of surgical treatment and outcome in 31 patients. Surg Neurol 1993;40:359-71.  Back to cited text no. 41
[PUBMED]    
42.
Sekhar LN, Pranatartiharan R, Chanda A, Wright DC. Chordomas and chondrosarcomas of the skull base: Results and complications of surgical management. Neurosurg Focus 2001;10:E2.  Back to cited text no. 42
    
43.
Stippler M, Gardner PA, Snyderman CH, Carrau RL, Prevedello DM, Kassam AB. Endoscopic endonasal approach for clival chordomas. Neurosurgery 2009;64:268-77.  Back to cited text no. 43
[PUBMED]    
44.
Gay E, Sekhar LN, Rubinstein E, Wright DC, Sen C, Janecka IP, et al. Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients. Neurosurgery 1995;36:887-96.  Back to cited text no. 44
[PUBMED]    
45.
Leung GK, Chan SK, Hung KN. Triology of neurosurgical complications after radiotherapy for nasopharyngeal carcinoma. Surg Neurol 2007;68:466-70.  Back to cited text no. 45
[PUBMED]    
46.
Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD. The role of palliative radiosurgery when cancer invades the cavernous sinus. Int J Radiat Oncol Biol Phys 2009;73:709-15.  Back to cited text no. 46
[PUBMED]    
47.
Ichimura S, Kawase T, Onozuka S, Yoshida K, Ohira T. Four subtypes of petroclival meningiomas: Differences in symptoms and operative findings using the anterior transpetrosal approach. Acta Neurochir (Wien) 2008;150:637-45.  Back to cited text no. 47
[PUBMED]    
48.
Nanda A, Javalkar V, Banerjee AD. Petroclival meningiomas: Study on outcomes, complications and recurrence rates. J Neurosurg 2011;114:1268-77.  Back to cited text no. 48
[PUBMED]    
49.
Koerbel A, Kirschniak A, Ebner FH, Tatagiba M, Gharabaghi A. The retrosigmoid intradural suprameatal approach to posterior cavernous sinus: Microsurgical anatomy. Eur J Surg Oncol 2009;35:368-72.  Back to cited text no. 49
[PUBMED]    
50.
Ebner FH, Koerbel A, Roser F, Hirt B, Tatagiba M. Microsurgical and endoscopic anatomy of the retrosigmoid intradural suprameatal approach to lesions extending from the posterior fossa to the central skull base. Skull Base 2009;19:319-23.  Back to cited text no. 50
[PUBMED]    
51.
Altay T, Patel BC, Couldwell WT. Lateral orbital wall approach to the cavernous sinus. J Neurosurg 2012;116:755-63.  Back to cited text no. 51
[PUBMED]    
52.
Dalgiç A, Boyaci S, Aksoy K. Anatomical study of the cavernous sinus emphasizing operative approaches. Turk Neurosurg 2010;20:186-204.  Back to cited text no. 52
    
53.
Hakuba A, Matsuoka Y, Suzuki T, Komiyama M, JiD TB, Inoue Y. Direct approaches to vascular lesions in the cavernous sinus via the medial triangle. In: Dolenc VV, editor. The Cavernous Sinus. Wien: Springer Verlag; 1987. p. 272-84.  Back to cited text no. 53
    
54.
Kobayashi M, Yoshida K, Kawase T. Inter-dural approach to parasellar tumors. Acta Neurochir (Wien) 2010;152:279-84.  Back to cited text no. 54
[PUBMED]    
55.
Krayenbühl N, Hafez A, Hernesniemi JA, Krisht AF. Taming the cavernous sinus: Technique of hemostasis using fibrin glue. Neurosurgery 2007;61 3 Suppl:E52.  Back to cited text no. 55
    
56.
Cavallo LM, Messina A, Cappabianca P, Esposito F, de Divitiis E, Gardner P, et al. Endoscopic endonasal surgery of the midline skull base: Anatomical study and clinical considerations. Neurosurg Focus 2005;19:E2.  Back to cited text no. 56
    
57.
Alfieri A, Jho HD. Endoscopic endonasal approaches to the cavernous sinus: Surgical approaches. Neurosurgery 2001;49:354-60.  Back to cited text no. 57
[PUBMED]    
58.
Komatsu F, Komatsu M, Di Ieva A, Tschabitscher M. Endoscopic extradural subtemporal approach to lateral and central skull base: A cadaveric study. World Neurosurg 2013;80:591-7.  Back to cited text no. 58
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
 
 
  Search
 
<
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
  Introduction
  Methods
  Results
  Discussion
  Conclusion
   References
   Article Figures

 Article Access Statistics
    Viewed132    
    Printed6    
    Emailed0    
    PDF Downloaded53    
    Comments [Add]    

Recommend this journal